middle.news
Challenger Surpasses ROE Targets with 9% NPAT Growth in FY25
8:12am on Tuesday 19th of August, 2025 AEST
•
Financial Services
Read Story
Challenger Surpasses ROE Targets with 9% NPAT Growth in FY25
8:12am on Tuesday 19th of August, 2025 AEST
Key Points
Normalised NPAT up 9% to $456 million
Statutory NPAT rises 48% to $192 million including unrealised gains
Normalised ROE improves 110 basis points to 11.8%, surpassing targets
Record retail lifetime and Japanese annuity sales fuel growth
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Challenger (ASX:CGF)
OPEN ARTICLE